ReliOn™ Premier Voice Basic Meter 780001Recalls & reported problems
Wal-Mart Stores, Inc. · The ReliOn Premier Voice Blood Glucose Monitoring System is intended for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips and alternative sites such as the forearm, palm, thigh and calf. · Class 1
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00681131169851), received between Aug 6, 2025 and Aug 11, 2025 — classified as 2 injuries.
The most frequently reported specific device problem is “Low Readings” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Low Readings2
Patient problems
- Hyperglycemia2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryAug 11, 2025Low Readings; Low Readings
THE CUSTOMER REPORTED THAT TWO DIFFERENT METERS, A RELION PREMIER CLASSIC AND A RELION PREMIER VOICE, AND TWO DIFFERENT LOTS OF PREMIER TEST STRIPS ARE READING TOO LOW WHICH CAUSED HER TO BELIEVE THAT HER BLOOD SUGAR WAS TOO LOW, SO SHE DRANK ORANGE JUICE TO RAISE HER BLOOD GLUCOSE LEVELS AND ENDED UP GOING TO THE EMERGENCY ROOM TO BE TREATED. SHE STATED HER NORMAL BLOOD GLUCOSE LEVELS ARE 90-100, HOWEVER SOMETIMES SHE RECEIVES LEVELS IN HIGHER HUNDREDS TO LOWER TWO HUNDREDS. SHE WAS RECEIVING RESULTS OF 50-60 TESTING WITH THESE PRODUCTS. WHEN ASKED ABOUT HAND CLEANSING, USING NEW LANCETS, AND BLOOD TESTING TECHNIQUES, SHE DESCRIBED PROPER BLOOD TESTING TECHNIQUES. WHEN ASKED ABOUT CONTROL SOLUTION AND TESTING THE METER AND STRIPS WITH CONTROL SOLUTION TO CHECK FOR ACCURACY, SHE STATED SHE DOES NOT HAVE CONTROL SOLUTION AND DOESN'T KNOW WHAT CONTROL SOLUTION IS. SHE INITIALLY DID NOT SEEK MEDICAL TREATMENT AND CONTINUED TO TEST WITH EACH METER AND TEST STRIPS AND CONTINUED TO RECEIVE LOW BLOOD GLUCOSE READINGS AND CONTINUED TO DRINK MORE ORANGE JUICE BASED ON THE LOW BLOOD GLUCOSE READINGS AND EVENTUALLY FELT SOMETHING WAS NOT RIGHT, HOWEVER SHE WAS NOT EXPERIENCING ANY SYMPTOMS, B
Patient problems: Hyperglycemia
MAUDE report 22768827 ↗InjuryAug 6, 2025Low Readings; Low Readings
THE CUSTOMER REPORTED THAT TWO DIFFERENT METERS, A RELION PREMIER CLASSIC AND A RELION PREMIER VOICE, AND TWO DIFFERENT LOTS OF PREMIER TEST STRIPS ARE READING TOO LOW WHICH CAUSED HER TO BELIEVE THAT HER BLOOD SUGAR WAS TOO LOW, SO SHE DRANK ORANGE JUICE TO RAISE HER BLOOD GLUCOSE LEVELS AND ENDED UP GOING TO THE EMERGENCY ROOM TO BE TREATED. SHE STATED HER NORMAL BLOOD GLUCOSE LEVELS ARE 90-100, HOWEVER, SOMETIMES SHE RECEIVES LEVELS IN HIGHER HUNDREDS TO LOWER TWO HUNDREDS. SHE WAS RECEIVING RESULTS OF 50-60 TESTING WITH THESE PRODUCTS. WHEN ASKED ABOUT HAND CLEANSING, USING NEW LANCETS, AND BLOOD TESTING TECHNIQUES, SHE DESCRIBED PROPER BLOOD TESTING TECHNIQUES. WHEN ASKED ABOUT CONTROL SOLUTION AND TESTING THE METER AND STRIPS WITH CONTROL SOLUTION TO CHECK FOR ACCURACY, SHE STATED SHE DOES NOT HAVE CONTROL SOLUTION AND DOESN'T KNOW WHAT CONTROL SOLUTION IS. SHE INITIALLY DID NOT SEEK MEDICAL TREATMENT AND CONTINUED TO TEST WITH EACH METER AND TEST STRIPS AND CONTINUED TO RECEIVE LOW BLOOD GLUCOSE READINGS AND CONTINUED TO DRINK MORE ORANGE JUICE BASED ON THE LOW BLOOD GLUCOSE READINGS AND EVENTUALLY FELT SOMETHING WAS NOT RIGHT, HOWEVER, SHE WAS NOT EXPERIENCING ANY SYMPTOMS,
Patient problems: Hyperglycemia
MAUDE report 22727538 ↗
Other Single (Specified) Analyte Controls (Assayed And Unassayed) devices
- CONTOUR® NEXT 7314Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)227 reports
- FastPack® IP SHBG FastPack® IP SHBG 30 ImmunoassayQualigen Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)2 recalls0 reports
- CONTOUR® NEXT 7377Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)95 reports
- ARCHITECT 7K62-25Abbott Ireland · SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED)94 reports
- ARCHITECT 08K2812Abbott GmbH · Single (specified) analyte controls (assayed and unassayed)1 recall12 reports
- CONTOUR® NEXT 9697Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)56 reports
- VITROS 6192257Ortho Clinical Diagnostics · Single (specified) analyte controls (assayed and unassayed)1 recall0 reports
- McKesson 5011Mckesson Medical-Surgical Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.